8-K: Core Scientific Completes $625 Million Convertible Notes Offering

Sentiment:

Convertible Notes Offering Announcement


Core Scientific successfully closed a private offering of $625 million in convertible senior notes due 2031, including the full exercise of the initial purchasers' option.

Capital raiseCore Scientific completed a private offering of $625 million in convertible senior notes due 2031.The offering included an option for the initial purchasers to buy an additional $75 million in notes, which was fully exercised.The company intends to use the net proceeds for general corporate purposes, including potential repurchases of its securities.

Summary

  • Core Scientific has finalized a private offering of $625 million in convertible senior notes due in 2031.
  • The offering includes the full exercise of the initial purchasers' option to buy an additional $75 million in notes.
  • The notes do not accrue regular interest and will mature on June 15, 2031, unless converted, redeemed, or repurchased earlier.
  • Noteholders can convert their notes into cash, shares of common stock, or a combination of both, under certain conditions.
  • The initial conversion rate is 44.4587 shares of common stock per $1,000 principal amount of notes, equivalent to a conversion price of approximately $22.49 per share.
  • The company can redeem the notes for cash starting June 22, 2028, if the stock price exceeds 130% of the conversion price for a specified period.
  • Noteholders have the option to have their notes repurchased by Core Scientific on December 15, 2027.
  • The company estimates net proceeds from the offering to be approximately $608.7 million after deducting expenses.
  • The funds will be used for general corporate purposes, including working capital, operating expenses, capital expenditures, acquisitions, and potential repurchases of securities.

Sentiment

Score: 7

Explanation: The document is generally positive, indicating a successful capital raise. However, the lack of regular interest on the notes and the conditions for conversion and redemption introduce some uncertainty.

Positives

  • The successful completion of the $625 million convertible notes offering provides Core Scientific with significant capital.
  • The funds can be used for various strategic purposes, including growth initiatives and potential acquisitions.
  • The notes offer flexibility with conversion options into cash, shares, or a combination of both.
  • The company has the option to redeem the notes, providing potential financial management flexibility.
  • Noteholders have a repurchase option, offering a degree of downside protection.

Negatives

  • The notes do not bear regular interest, which may be less attractive to some investors.
  • The conversion of notes is subject to certain conditions and may not always be available to noteholders.
  • The company's ability to redeem the notes is contingent on the stock price exceeding 130% of the conversion price.
  • The notes are unsecured obligations, which may increase the risk for noteholders.

Risks

  • The notes are subject to market conditions and may be affected by fluctuations in the company's stock price.
  • The company's ability to redeem the notes is contingent on the stock price exceeding 130% of the conversion price, which may not occur.
  • The company's ability to use the net proceeds effectively for its intended purposes is not guaranteed.
  • The notes are unsecured obligations, which may increase the risk for noteholders.
  • The conversion of notes is subject to certain conditions and may not always be available to noteholders.

Future Outlook

The company intends to use the net proceeds from the offering for general corporate purposes, including working capital, operating expenses, capital expenditures, acquisitions of complementary businesses, or other repurchases of its securities.

Industry Context

This offering reflects a trend of companies in the digital asset and high-performance computing sectors seeking capital through convertible debt instruments. The funds raised can be used to expand operations, invest in new technologies, or strengthen their balance sheets.

Comparison to Industry Standards

  • The use of convertible notes is a common financing method for growth companies, particularly in the technology sector.
  • The conversion premium of approximately 42.5% over the recent trading price is within the typical range for such offerings.
  • The terms of the notes, including the redemption and repurchase options, are generally consistent with industry standards for convertible debt.
  • Comparable companies in the digital asset mining space have also utilized similar financing methods to fund their operations and growth.

Stakeholder Impact

  • Shareholders may experience dilution if the notes are converted into common stock.
  • Employees may benefit from the company's increased financial stability and growth potential.
  • Customers may benefit from the company's ability to invest in infrastructure and services.
  • Creditors may be impacted by the new debt obligations.
  • Suppliers may benefit from the company's increased financial stability and growth potential.

Next Steps

  • The company will use the net proceeds for general corporate purposes.
  • The company will monitor the stock price to determine if the conditions for redemption are met.
  • Noteholders will monitor the stock price and other conditions to determine if and when to convert their notes.

Key Dates

DateDescription
December 2, 2024Date of the initial press release announcing the proposed offering and the pricing of the offering.
December 5, 2024Date of the indenture and the completion of the private offering.
June 15, 2031Maturity date of the convertible senior notes.
June 22, 2028Earliest date the company can redeem the notes.
December 15, 2027Date on which noteholders can require the company to repurchase their notes.
March 17, 2031Date from which noteholders may convert their notes at any time at their election until the close of business on the scheduled trading day immediately before the maturity date.

Keywords

convertible notes, senior notes, private offering, capital raise, debt financing, Core Scientific, bitcoin mining, high-performance computing, convertible securities, Rule 144A

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.